Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Lesoleil
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Preclinical
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Suntrap Discovered 'LeSoleil' for COVID-19 and the Epidemic
Details : LeSoleil' series of drugs can block the broad-spectrum coronavirus infection, resist further development of respiratory infection and kill the viruses.
Product Name : Lesoleil
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
February 14, 2021
Lead Product(s) : Lesoleil
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Preclinical
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Lesoleil
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Preclinical
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Suntrap Life Technologies Discovers Natural anti-COVID-19 Compound
Details : LeSoleil', a naturally active compound, was discovered as a therapeutic candidate for use against COVID-19. Results from a study conducted by Suntrap Life Technologies indicated 'LeSoleil' has a potent in vitro inhibitory effect on COVID-19.
Product Name : Lesoleil
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
December 24, 2020
Lead Product(s) : Lesoleil
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Preclinical
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable